Delivery Order SPE2DB22D3009-SPE2DB25FBD09
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100-count units) with a ceiling value of $4,221.50. This competitively awarded, firm fixed-price delivery order is set to be completed by August 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 10 mg capsules (100-count units) with a ceiling value of $1,278.13. This competitively awarded, firm fixed-price delivery order is set to be completed by July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100 count units) with a ceiling value of $2,047.19. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. No set-aside designation was used for this award, indicating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 20 mg capsules (100-count units) under a firm fixed-price contract. The award, issued on August 5, 2025, carries a ceiling value of $12,115.04 and requires completion by August 6, 2025. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded a $1,111.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count). This delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Lisdexamfetamine 10 mg capsules (100 count) with a ceiling value of $1,501.54. This firm fixed-price delivery order, which must be completed by July 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $6,288.73 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 60 mg capsules (100 count) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine 50 mg capsules in quantities of 100 units, with a ceiling value of $1,006.89. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,883.72 for Lisdexamfetamine 30 mg capsules (100-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under the company's broader pharmaceutical supply arrangements with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Lisdexamfetamine 60 mg capsules (100-count units) with a contract value of $1,525.84. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. As a child...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBD09Delivery Order
The Defense Logistics Agency awarded a $3,602.60 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100-count units). This contract utilizes a firm fixed-price structure with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive global pharmaceutical support vehicle. The company supplies a wide range of pharmaceutical products and medical supplies to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Through this delivery order, the contractor will provide amphetamine-based pharmaceutical treatment used for attention deficit hyperactivity disorder and narcolepsy to support Defense Health Agency requirements and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/13/25 |